Ignite Creation Date:
2025-12-24 @ 7:30 PM
Ignite Modification Date:
2026-03-01 @ 11:20 PM
Study NCT ID:
NCT05327803
Status:
TERMINATED
Last Update Posted:
2025-05-08
First Post:
2022-03-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
Sponsor:
AN2 Therapeutics, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-18
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-24
First Submit QC Date:
None
Study First Post Date:
2022-04-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-06
Last Update Post Date:
2025-05-08
Last Update Post Date Type:
ACTUAL